The firm, established in 2008, focuses on medical device, digital health, and platform technology sectors, and currently manages €50 million through its fund Peppermint CBF-1. PVP has a unique partnership with Charité Medical School in Berlin, providing access to a large medical university hospital network. The investment focus is on companies with patent-protected technologies that address unmet medical needs, improve diagnosis and therapy of diseases, and reduce healthcare costs. The portfolio currently comprises 8 companies.